ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 40 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $37,000 | – | 22,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,950,949 | $1,092,000 | 0.45% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $829,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 158,900 | $86,000 | 0.06% |
| Atom Investors LP | 113,151 | $63,000 | 0.03% |
| Nantahala Capital Management | 774,767 | $434,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,173,000 | 0.02% |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $659,000 | 0.01% |
| Altshuler Shaham Ltd | 1,088,848 | $609,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 309,400 | $173,000 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $328,000 | 0.00% |